81 POSTER Preclinical pharmacodynamic markers of MGCD265, a potent orally active c-Met/VEGFR multitargeted kinase inhibitor in Phase I clinical trials
| Autor: | Beaulieu, N., Dupont, I., Beaulieu, C., Nguyen, H., Ste-Croix, H., Claridge, S., Isakovic, L., Vaisburg, A., Besterman, J.M., Maroun, C. |
|---|---|
| Zdroj: | In EJC Supplements 2008 6(12):28-28 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect